Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin JE00B2QKY057
Ticker SHPGF
Company SHIRE
Currency $
Price
Aware Investor Index (AII) 0.0057
Recommendation STRONG SELL
P/E 43.41
ROE 3.54 %
Capitalization 55,650,240,000 $
Dividend Yield 0.51 %
P/S 3.67
AII Position 638
P/E Position 565
ROE Position 675
Capitalization Position 150
Dividend Yield Position 573
Sales 15,160,600,000 $
10-Year Average Earnings 1,281,890,000 $
Shares Outstanding 912,000,000
Equity 36,176,400,000 $
Dividend per Share 0.31 $
Industry Pharmaceutical
Country Jersey
SHIRE Investor Relations Web Site http://investors.shire.com/







Sales:

YEAR MONTH AMOUNT
2017 12 15,160,600,000.00 $
2016 12 11,396,600,000.00 $
2015 12 6,416,700,000.00 $
2014 12 6,022,100,000.00 $
2013 12 4,934,300,000.00 $

Earnings:

YEAR MONTH AMOUNT
2017 12 4,271,500,000.00 $
2016 12 327,400,000.00 $
2015 12 1,303,400,000.00 $
2014 12 3,405,500,000.00 $
2013 12 665,100,000.00 $
2012 12 745,400,000.00 $
2011 12 865,000,000.00 $
2010 12 588,000,000.00 $
2009 12 491,600,000.00 $
2008 12 156,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2017 12 36,176,400,000.00 $
2016 12 28,948,000,000.00 $
2015 12 9,829,100,000.00 $
2014 12 8,662,900,000.00 $
2013 12 5,366,000,000.00 $
2012 12 3,809,200,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 912,000,000
2016 12 776,200,000
2015 12 593,100,000
2014 12 591,300,000
2013 12 590,300,000
2012 12 593,500,000

 












Bloomberg News for SHIRE:



Google News for SHIRE:

Winslow Record - 1 day ago
Session Review: Wilder Moving Average is Above Simple MA for ...
Watching the trading indicators on shares of Shire Plc Ord (SHPGF), we can see that the twenty one day Wilder Moving Average is presently ...
Parker City News - 5 days ago
Is Shire Plc Ord (SHPGF) a Buy? What Does the Relative Strength ...
The momentum-investing technique that compares the performance of a commodity to that of the overall market is called Relative Strength.
Tremont Herald - 1 Nov 2018
Market Focus: Shares Pushing Higher 2.40% Over the Last Month ...
Zooming in on shares of Shire Plc Ord (SHPGF) we have seen that the stock price has gained 2.40% over the last 4-weeks. If we look back over ...
Seeking Alpha - 26 Apr 2018
Shire's Share Prices And Takeda's Deal Price Are Getting Closer
To get a better handle on what's going on between Takeda (OTCPK:TKPHF) ((4502 JP)) and Shire PLC (NASDAQ:SHPG) ((SHP LN)) and the ...
Seeking Alpha - 29 Mar 2018
Takeda Takes A Turn At Shire's Risky M&A Strategy
By Breakingviews. Takeda Pharmaceutical (OTCPK:TKPYY) (OTCPK:TKPHF) may take a turn at Shire's (NASDAQ:SHPG) (OTCPK:SHPGF) ...
Seeking Alpha - 19 May 2017
Shire Scores Another Rare Disease Win, But Will CSL Get There First?
Keenly awaited phase III data on Shire's (NASDAQ:SHPG) (OTCPK:SHPGF) hereditary angioedema (HAE) antibody, lanadelumab, appear to ...
Seeking Alpha - 5 Jan 2017
The Threats And Opportunities In Hereditary Angioedema: What ...
Hereditary Angioedema (HAE) is one of key growth franchise for Shire (NASDAQ:SHPG) (OTCPK:SHPGF), accounting for around $1.2B in ...
Seeking Alpha - 19 Sep 2018
Deciphera Pharmaceuticals: Will This ASCO Winner Repeat At ...
The share price has essentially doubled since last year's IPO. The valuation gap with larger competitor Blueprint Medicines appears enticing, ...
Seeking Alpha - 4 Jan 2017
The Opportunities For Shire In Immunology: What The Market Is ...
Shire (NASDAQ:SHPG) (OTCPK:SHPGF) hosted an Investor Day on Thursday 10th November to discuss its business strategies and to help ...
Fortune - 8 Jan 2016
Shire's Merger With Baxalta Merger Is Nearly Done
Shire Pharmaceuticals Plc (shpgf, -1.67%) is preparing to announce it's buying U.S. peer Baxalta (bxlt, +0.00%) for roughly $32.5 billion as ...


Back